Article information
Full text is only aviable in PDF
Bibliografía
[1.]
F. Bardinas, J. Morera, E. Fite, A. Plasencia.
Seasonal clustering of sarcoidosis.
Lancet, 2 (1989), pp. 455-456
[2.]
S.A. Parkes, S.B. Baker, R.E. Bourdillon, C.R. Murray, M. Rakshit.
Epidemiology of sarcoidosis in the Isle of Man. 1: a case controlled study.
Thorax, 42 (1987), pp. 420-426
[3.]
S.E. Hills, S.A. Parkes, S.B. Baker.
Epidemiology of sarcoidosis in the Isle of Man 2: evidence for space-time clustering.
Thorax, 42 (1987), pp. 427-430
[4.]
W.M. Edmonstone.
Sarcoidosis in nurses: is there an association?.
Thorax, 43 (1988), pp. 342-343
[5.]
D.G. Kern, M.A. Neill, D.S. Wrenn, J.C. Varone.
Investigation of a unique time-space cluster of sarcoidosis in firefighters.
Am Rev Respir Dis, 148 (1993), pp. 974-980
[6.]
L.S. Newman, C.S. Rose, L.A. Maier.
Sarcoidosis..
N Engl J Med, 336 (1997), pp. 1.224-1.234
[7.]
W.M.J. Burke, A. Keogh, P.J. Maloney, W. Delprado, D.H. Bryant, P. Spratt.
Transmission of sarcoidosis via cardiac transplantation.
Lancet, 336 (1990), pp. 1.579
[8.]
A. Heyll, G. Meckenstock, C. Aul, D. Söhngen, F. Borchard, U. Hadding, et al.
Possible transmission of sarcoidosis via allogeneic bone marrow transplantation.
Bone Marrow Transplant, 14 (1994), pp. 161-164
[9.]
G. Mangiapan, A.J. Hance.
Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data.
Sarcoidosis, 12 (1995), pp. 20-37
[10.]
S. Bello Dronda.
Infeccidn respiratoria por Chlamydia pneumoniae.
Actualizaciones SEPAR, 2 (1996), pp. 141-172
[11.]
M. Turner-Warwick, W. McAllister, R. Lawrence, A. Britten, P.L. Haslam.
Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?.
Thorax, 41 (1986), pp. 903-913
[12.]
M. Laviolette, J. La Forge, S. Tennina, L.P. Boulet.
Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis.
Chest, 100 (1991), pp. 380-384
[13.]
A. Miller, L.K. Brown, M.F. Sloane, A. Bhuptani, A.S. Teirstein.
Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry.
Chest, 107 (1995), pp. 323-329
[14.]
J. Murdoch, N.L. Müller.
Pulmonary sarcoidosis: changes of followup CT examination.
Am J Roentgenol, 159 (1992), pp. 473-477
[16.]
H.L. Israel, D.W. Fronts, R.A. Beggs.
A controlled clinical trial of prednisone treatment of sarcoidosis.
Am Rev Respir Dis, 107 (1973), pp. 609-614
[17.]
G.W. Hunninghake, S. Gilbert, R. Pueringer, C. Dayton, C. Floerchinger, R. Helmers, et al.
Outcome of the treatment for sarcoidosis.
Am J Respir Crit Care Med, 149 (1994), pp. 893-898
[18.]
G.J. Gibson, R.J. Prescott, M.F. Muers, W.G. Middleton, D.N. Mitchell, C.K. Connolly, et al.
British Thoracic Society Sarcoidosis study: effects of long-term corticosteroid treatment.
Thorax, 51 (1996), pp. 238-247
[19.]
J.E. Gottlieb, H.L. Israel, R.M. Steiner, J. Triolo, H. Patrick.
Outcome of sarcoidosis. The relationship of relapse to corticosteroid therapy..
Chest, 111 (1997), pp. 623-631
[20.]
M.J. Lacher.
Spontaneous remission response to methotrexatein sarcoidosis.
Ann Intern Med, 69 (1968), pp. 1.247-1.248
[21.]
R.P. Baughman, E.E. Lower.
The effect of corticosteroid or methotrexate therapy on lang lymphocytes and macrophages in sarcoidosis.
Am Rev Respir Dis, 142 (1990), pp. 1.268-1.271
[22.]
A. Gedalia, J.F. Molina, G.S. Ellis Jr., W. Galen, C. Moore, L.R. Espinoza.
Low-dose methotrexate therapy for childhood sarcoidosis.
J Pediatr, 130 (1997), pp. 25-29
[23.]
E.E. Lower, R.P. Baughman.
Prolonged use of methotrexate for sarcoidosis.
Arch Intern Med, 155 (1995), pp. 846-851
[24.]
E.L. York, T. Kovithavongs, P. Man, A.S. Rebuck, B.J. Sproule.
Cyclosporine and chronic sarcoidosis.
Chest, 98 (1990), pp. 1.026-1.029
[25.]
C.P. Wyser, E.M. Van Schalkwyk, B. Alheit, P.G. Bardin, J.R. Joubert.
Treatment of progresive pulmonary sarcoidosis with cyclosporin A: a randomized controlled trial.
Am J Respir Crit Care Med, 156 (1997), pp. 1.371-1.376
[26.]
P. Zabel, P. Entzian, K. Dalhoff, M. Schlaak.
Pentoxifylline in treatment of sarcoidosis.
Am J Respir Crit Care Med, 155 (1997), pp. 1.665-1.669
[28.]
D.G. Hof, P.C. Hof, W.A. Godfrey.
Long-term use of azathioprine as steroid-sparing treatment for chronic sarcoidosis.
Am J Respir Crit Care Med, 153 (1996), pp. 870
[29.]
J.M. Casas, J.M. Sánchez-Alarcos, J.L. Álvarez-Sala.
¿Son útiles los esteroides inhalados en la sarcoidosis pulmonar?.
Arch Bronconeumol, 31 (1995), pp. 256-257
[30.]
C. Alberts, T.W. Van der Mark, H.M. Jansen.
Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis.
Eur Respir J, 8 (1995), pp. 682-688
[31.]
N. Milman, N. Graudal, G. Grode, E. Munch.
No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study.
J Intern Med, 236 (1994), pp. 285-290
[32.]
O. Selroos, A.B. Lofroos, A. Pietinalho, M. Niemisto, H. Riska.
Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis.
Sarcoidosis, 11 (1994), pp. 126-131
Copyright © 1998. Sociedad Española de Neumología y Cirugía Torácica
